SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-23-036056
Filing Date
2023-07-25
Accepted
2023-07-25 16:19:21
Documents
1
Group Members
GEORGE R. ROBERTSHENRY R. KRAVISKKR & CO. INC.KKR GROUP CO. INC.KKR GROUP HOLDINGS CORP.KKR GROUP PARTNERSHIP L.P.KKR MANAGEMENT LLPKKR PHORM INVESTORS GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13DA brhc20056310_sc13da.htm SC 13D/A 305889
  Complete submission text file 0001140361-23-036056.txt   307802
Mailing Address 75 CASTILIAN DRIVE GOLETA CA 93117
Business Address 75 CASTILIAN DRIVE GOLETA CA 93117 805-456-1300
Transphorm, Inc. (Subject) CIK: 0001715768 (see all company filings)

IRS No.: 821858829 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-90877 | Film No.: 231108769
SIC: 3674 Semiconductors & Related Devices

Mailing Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001
Business Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001 212-230-9742
KKR Phorm Investors L.P. (Filed by) CIK: 0001806548 (see all company filings)

IRS No.: 473998300 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A